Follow
Sherazaan D. Ismail
Sherazaan D. Ismail
Verified email at uct.ac.za
Title
Cited by
Cited by
Year
Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants
P Selhorst, L Masson, SD Ismail, N Samsunder, N Garrett, LE Mansoor, ...
Clinical Infectious Diseases 64 (1), 79-82, 2017
512017
SARS-CoV-2 antigens expressed in plants detect antibody responses in COVID-19 patients
MS Makatsa, MB Tincho, JM Wendoh, SD Ismail, R Nesamari, F Pera, ...
Frontiers in Plant Science 12, 550, 2021
452021
Addressing an HIV cure in LMIC
SD Ismail, J Pankrac, E Ndashimye, JL Prodger, MR Abrahams, ...
Retrovirology 18 (1), 1-19, 2021
352021
Replication capacity of viruses from acute infection drives HIV-1 disease progression
P Selhorst, C Combrinck, N Ndabambi, SD Ismail, MR Abrahams, ...
Journal of virology 91 (8), 10.1128/jvi. 01806-16, 2017
192017
Immunological correlates of the HIV-1 replication-competent reservoir size
SD Ismail, C Riou, SB Joseph, NM Archin, DM Margolis, AS Perelson, ...
Clinical Infectious Diseases 73 (8), 1528-1531, 2021
62021
Advancing HIV cure research in low-and middle-income countries requires empowerment of the next generation of scientists
R Tatoud, RB Jones, K Dong, T Ndung'u, S Deeks, CT Tiemessen, ...
Journal of Virus Eradication, 100364, 2024
2024
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus
SB Joseph, MR Abrahams, M Moeser, L Tyers, NM Archin, OD Council, ...
PLoS pathogens 20 (2), e1011974, 2024
2024
Characterizing the cellular latent reservoir of HIV-1 and the effect of immune activation on characteristics of the reservoir
SD Ismail
2022
Characterisation of HIV-1 Envelope features of breakthrough infections from the CAPRISA 004 Microbicide Trial
SD Ismail
2016
The system can't perform the operation now. Try again later.
Articles 1–9